ONTOLOGY REPORT - ANNOTATIONS
| Term: | phenytoin |
|
| Accession: | CHEBI:8107
|
browse the term
|
| Definition: | A imidazolidine-2,4-dione that consists of hydantoin bearing two phenyl substituents at position 5. |
| Synonyms: | related_synonym: | 5,5-Diphenyl-imidazolidine-2,4-dione; 5,5-diphenylimidazolidine-2,4-dione; 5,5-diphenyltetrahydro-1H-2,4-imidazoledione; C15H12N2O2; DILANTIN; InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19); InChIKey=CXOFVDLJLONNDW-UHFFFAOYSA-N; O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1; PHENTYTOIN |
| | alt_id: | CHEBI:100921 |
| | xref_casrn: | 57-41-0 |
| | xref: | Beilstein:384532 "Beilstein Registry Number"; ChEMBL:100921 "ChEMBL COMPOUND"; ChemIDplus:57-41-0 "CAS Registry Number"; CiteXplore:7602118 "PubMed citation"; DrugBank:DB00252 "DrugBank"; KEGG COMPOUND:57-41-0 "CAS Registry Number"; KEGG COMPOUND:C07443 "KEGG COMPOUND"; KEGG DRUG:D00512 "KEGG DRUG" |
| | xref_mesh: | MESH:D010672 |
| | xref: | Wikipedia:Phenytoin "Wikipedia" |
|
|
phenytoin
|
| G |
Aaas |
achalasia, adrenocortical insufficiency, alacrimia |
|
decreases expression |
EXP |
7 |
141,088,006 |
141,107,581 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
decreases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects abundance |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects response to substance |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases metabolic processing |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
EXP |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases activity |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
EXP |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects abundance |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects response to substance |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects response to substance |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
EXP |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects response to substance |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
affects abundance |
ISO |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases expression |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects transport |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects transport |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
EXP |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
decreases expression |
ISO |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Abhd5 |
abhydrolase domain containing 5 |
|
increases expression |
EXP |
8 |
122,148,937 |
122,173,147 |
RGD:6480464 |
CTD |
| G |
Ablim1 |
actin-binding LIM protein 1 |
|
decreases expression |
ISO |
1 |
263,380,818 |
263,465,905 |
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
decreases expression |
ISO |
1 |
199,780,772 |
199,791,855 |
RGD:6480464 |
CTD |
| G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
increases expression |
EXP |
4 |
126,996,604 |
127,198,909 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
decreases expression |
EXP |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
decreases expression |
ISO |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
|
decreases expression |
EXP |
4 |
6,038,279 |
6,064,813 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akap10 |
A kinase (PRKA) anchor protein 10 |
|
increases expression |
EXP |
10 |
48,031,107 |
48,087,922 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Amn1 |
antagonist of mitotic exit network 1 homolog (S. cerevisiae) |
|
increases expression |
EXP |
4 |
186,585,328 |
186,612,239 |
RGD:6480464 |
CTD |
| G |
Anxa4 |
annexin A4 |
|
increases expression |
ISO |
4 |
120,889,617 |
120,947,662 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
increases expression |
ISO |
8 |
49,233,142 |
49,233,431 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
increases expression |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases activity |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arfip1 |
ADP-ribosylation factor interacting protein 1 |
|
increases expression |
EXP |
2 |
176,275,425 |
176,353,675 |
RGD:6480464 |
CTD |
| G |
Arhgap39 |
Rho GTPase activating protein 39 |
|
increases expression |
EXP |
7 |
114,776,991 |
114,866,861 |
RGD:6480464 |
CTD |
| G |
Armc8 |
armadillo repeat containing 8 |
|
increases expression |
EXP |
8 |
104,341,558 |
104,436,086 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
|
decreases expression |
EXP |
5 |
136,049,177 |
136,075,532 |
RGD:6480464 |
CTD |
| G |
B4galt7 |
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 |
|
decreases expression |
EXP |
17 |
15,059,958 |
15,068,556 |
RGD:6480464 |
CTD |
| G |
Bai3 |
brain-specific angiogenesis inhibitor 3 |
|
increases expression |
EXP |
9 |
23,759,340 |
24,495,409 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
decreases expression |
ISO |
15 |
50,878,144 |
50,922,313 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
increases expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
C2 |
complement component 2 |
|
decreases expression |
EXP |
20 |
4,051,146 |
4,071,909 |
RGD:6480464 |
CTD |
| G |
Cacybp |
calcyclin binding protein |
|
increases expression |
EXP |
13 |
75,623,161 |
75,633,644 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
decreases expression |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calm2 |
calmodulin 2 |
|
decreases expression |
ISO |
6 |
64,161,641 |
64,162,751 |
RGD:6480464 |
CTD |
| G |
Capn5 |
calpain 5 |
|
decreases expression |
ISO |
1 |
155,366,678 |
155,421,183 |
RGD:6480464 |
CTD |
| G |
Car6 |
carbonic anhydrase 6 |
|
increases expression |
EXP |
5 |
167,332,219 |
167,350,880 |
RGD:6480464 |
CTD |
| G |
Caskin1 |
CASK interacting protein 1 |
|
affects expression |
EXP |
10 |
13,740,593 |
13,760,485 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases response to substance |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbll1 |
Cbl proto-oncogene, E3 ubiquitin protein ligase-like 1 |
|
increases expression |
EXP |
6 |
49,352,961 |
49,366,947 |
RGD:6480464 |
CTD |
| G |
Ccbl1 |
cysteine conjugate-beta lyase, cytoplasmic |
|
increases activity |
EXP |
3 |
9,195,737 |
9,209,545 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
increases expression |
EXP |
5 |
36,465,490 |
36,483,538 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
multiple interactions |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cd47 |
Cd47 molecule |
|
decreases expression |
EXP |
11 |
52,098,355 |
52,158,169 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
decreases expression |
ISO |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeo box 2 |
|
increases expression |
EXP |
12 |
8,296,103 |
8,303,643 |
RGD:6480464 |
CTD |
| G |
Cela2a |
chymotrypsin-like elastase family, member 2A |
|
decreases expression |
ISO |
5 |
160,722,053 |
160,731,804 |
RGD:6480464 |
CTD |
| G |
Cep57 |
centrosomal protein 57 |
|
increases expression |
EXP |
8 |
10,608,688 |
10,627,914 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
multiple interactions |
ISO |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
increases expression |
ISO |
1 |
78,762,202 |
78,772,681 |
RGD:6480464 |
CTD |
| G |
Clcn6 |
chloride channel, voltage-sensitive 6 |
|
decreases expression |
EXP |
5 |
165,079,773 |
165,110,594 |
RGD:6480464 |
CTD |
| G |
Cmpk1 |
cytidine monophosphate (UMP-CMP) kinase 1 |
|
increases expression |
EXP |
5 |
135,320,845 |
135,348,973 |
RGD:6480464 |
CTD |
| G |
Cnot7 |
CCR4-NOT transcription complex, subunit 7 |
|
increases expression |
EXP |
16 |
55,118,260 |
55,137,733 |
RGD:6480464 |
CTD |
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
increases expression |
ISO |
2 |
209,996,467 |
210,193,379 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
decreases expression |
ISO |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col6a1 |
collagen, type VI, alpha 1 |
|
decreases expression |
ISO |
20 |
12,320,102 |
12,338,500 |
RGD:6480464 |
CTD |
| G |
Col6a1 |
collagen, type VI, alpha 1 |
|
increases expression |
ISO |
20 |
12,320,102 |
12,338,500 |
RGD:6480464 |
CTD |
| G |
Col6a2 |
collagen, type VI, alpha 2 |
|
increases expression |
ISO |
20 |
12,436,783 |
12,464,512 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
increases expression |
ISO |
9 |
89,990,129 |
90,043,697 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
decreases expression |
EXP |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cpsf6 |
cleavage and polyadenylation specific factor 6, 68kDa |
|
increases expression |
EXP |
7 |
56,658,291 |
56,689,892 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
affects expression |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
increases expression |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
decreases activity |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
decreases activity |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cul4a |
cullin 4A |
|
increases expression |
EXP |
16 |
81,242,293 |
81,279,498 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
increases expression |
EXP |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
decreases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
multiple interactions |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
multiple interactions |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
multiple interactions |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases activity |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
multiple interactions |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
multiple interactions |
ISO |
1 |
81,084,984 |
81,185,251 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases hydroxylation |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases hydroxylation |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases response to substance |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
affects metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases expression |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases metabolic processing |
EXP |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases hydroxylation |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases hydroxylation |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases hydroxylation |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases hydroxylation |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases hydroxylation |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases activity |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
decreases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
increases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
increases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
increases expression |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Dap3 |
death associated protein 3 |
|
increases expression |
ISO |
2 |
180,987,242 |
181,014,360 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Dhx9 |
DEAH (Asp-Glu-Ala-His) box helicase 9 |
|
increases expression |
EXP |
13 |
68,471,256 |
68,507,999 |
RGD:6480464 |
CTD |
| G |
Dmtn |
dematin actin binding protein |
|
decreases expression |
EXP |
15 |
51,004,498 |
51,032,118 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
multiple interactions |
ISO |
5 |
58,100,794 |
58,111,705 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
multiple interactions |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
Ebpl |
emopamil binding protein-like |
|
increases expression |
EXP |
15 |
40,484,464 |
40,506,451 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr3 |
early growth response 3 |
|
increases expression |
EXP |
15 |
50,477,453 |
50,479,909 |
RGD:6480464 |
CTD |
| G |
Eif1a |
eukaryotic translation initiation factor 1A |
|
increases expression |
EXP |
18 |
40,808,057 |
40,819,421 |
RGD:6480464 |
CTD |
| G |
Emx2 |
empty spiracles homeobox 2 |
|
decreases expression |
ISO |
1 |
266,004,257 |
266,011,265 |
RGD:6480464 |
CTD |
| G |
Enpep |
glutamyl aminopeptidase |
|
decreases expression |
EXP |
2 |
226,731,079 |
226,732,069 |
RGD:6480464 |
CTD |
| G |
Enpep |
glutamyl aminopeptidase |
|
increases expression |
EXP |
2 |
226,731,079 |
226,732,069 |
RGD:6480464 |
CTD |
| G |
Eomes |
eomesodermin |
|
increases expression |
ISO |
8 |
123,376,689 |
123,383,451 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
affects response to substance |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
decreases expression |
EXP |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
F10 |
coagulation factor X |
|
decreases expression |
EXP |
16 |
81,327,237 |
81,346,544 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fbxl3 |
F-box and leucine-rich repeat protein 3 |
|
increases expression |
EXP |
15 |
87,093,141 |
87,113,003 |
RGD:6480464 |
CTD |
| G |
Fbxo30 |
F-box protein 30 |
|
increases expression |
EXP |
1 |
5,975,207 |
5,991,214 |
RGD:6480464 |
CTD |
| G |
Fgf12 |
fibroblast growth factor 12 |
|
increases expression |
EXP |
11 |
74,208,696 |
74,481,037 |
RGD:6480464 |
CTD |
| G |
Fgf5 |
fibroblast growth factor 5 |
|
increases expression |
ISO |
14 |
12,713,971 |
12,734,634 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
increases expression |
ISO |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
increases expression |
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
|
increases expression |
ISO |
6 |
119,569,366 |
119,658,949 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
multiple interactions |
ISO |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo4 |
flavin containing monooxygenase 4 |
|
multiple interactions |
ISO |
13 |
78,476,211 |
78,494,458 |
RGD:6480464 |
CTD |
| G |
Fmod |
fibromodulin |
|
decreases expression |
ISO |
13 |
46,987,714 |
46,998,331 |
RGD:6480464 |
CTD |
| G |
Fmr1 |
fragile X mental retardation 1 |
|
increases expression |
EXP |
X |
154,756,031 |
154,793,782 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fndc3a |
fibronectin type III domain containing 3a |
|
increases expression |
EXP |
15 |
53,124,740 |
53,312,367 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Frs3 |
fibroblast growth factor receptor substrate 3 |
|
decreases expression |
ISO |
9 |
8,754,714 |
8,761,537 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
decreases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
affects response to substance |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
multiple interactions |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
EXP |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gnl2 |
guanine nucleotide binding protein-like 2 (nucleolar) |
|
increases expression |
EXP |
5 |
144,373,848 |
144,399,235 |
RGD:6480464 |
CTD |
| G |
Gnpda2 |
glucosamine-6-phosphate deaminase 2 |
|
increases expression |
EXP |
14 |
41,048,839 |
41,067,584 |
RGD:6480464 |
CTD |
| G |
Gpm6a |
glycoprotein m6a |
|
increases expression |
EXP |
16 |
39,670,748 |
39,783,384 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
increases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
increases expression |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
decreases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
decreases expression |
ISO |
4 |
69,999,767 |
70,004,086 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
multiple interactions |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
multiple interactions |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
decreases expression |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gusb |
glucuronidase, beta |
|
multiple interactions |
ISO |
12 |
27,744,409 |
27,757,755 |
RGD:6480464 |
CTD |
| G |
Gusb |
glucuronidase, beta |
|
decreases activity |
ISO |
12 |
27,744,409 |
27,757,755 |
RGD:6480464 |
CTD |
| G |
Helz |
helicase with zinc finger |
|
increases expression |
EXP |
10 |
96,952,234 |
97,091,028 |
RGD:6480464 |
CTD |
| G |
Hexim1 |
hexamethylene bis-acetamide inducible 1 |
|
increases expression |
EXP |
10 |
92,290,289 |
92,292,401 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
increases expression |
EXP |
4 |
79,700,327 |
79,704,116 |
RGD:6480464 |
CTD |
| G |
Hook3 |
hook homolog 3 (Drosophila) |
|
increases expression |
EXP |
16 |
70,338,144 |
70,424,173 |
RGD:6480464 |
CTD |
| G |
Hoxa2 |
homeo box A2 |
|
decreases expression |
ISO |
4 |
80,462,651 |
80,464,927 |
RGD:6480464 |
CTD |
| G |
Hspa1l |
heat shock protein 1-like |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
multiple interactions |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
multiple interactions |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
multiple interactions |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifngr1 |
interferon gamma receptor 1 |
|
increases expression |
ISO |
1 |
14,846,369 |
14,864,804 |
RGD:6480464 |
CTD |
| G |
Ifngr2 |
interferon gamma receptor 2 |
|
increases expression |
ISO |
11 |
31,508,721 |
31,526,993 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
increases expression |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Ihh |
Indian hedgehog |
|
increases expression |
ISO |
9 |
74,287,115 |
74,293,332 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
decreases expression |
ISO |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Inpp5f |
inositol polyphosphate-5-phosphatase F |
|
increases expression |
EXP |
1 |
187,868,447 |
187,948,236 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
increases expression |
ISO |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Ipp |
intracisternal A particle-promoted polypeptide |
|
increases expression |
EXP |
5 |
136,794,175 |
136,825,352 |
RGD:6480464 |
CTD |
| G |
Irf9 |
interferon regulatory factor 9 |
|
increases expression |
EXP |
15 |
33,739,755 |
33,744,958 |
RGD:6480464 |
CTD |
| G |
Ispd |
isoprenoid synthase domain containing |
|
increases expression |
EXP |
6 |
55,139,155 |
55,419,630 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin, alpha 2 |
|
decreases expression |
ISO |
2 |
46,967,681 |
47,080,909 |
RGD:6480464 |
CTD |
| G |
Itga8 |
integrin, alpha 8 |
|
increases expression |
ISO |
17 |
86,427,191 |
86,649,268 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
decreases expression |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb3bp |
integrin beta 3 binding protein (beta3-endonexin) |
|
increases expression |
EXP |
5 |
120,459,569 |
120,525,476 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
increases expression |
EXP |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
decreases activity |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Kctd3 |
potassium channel tetramerisation domain containing 3 |
|
increases expression |
EXP |
13 |
105,117,483 |
105,155,705 |
RGD:6480464 |
CTD |
| G |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
|
increases expression |
EXP |
9 |
30,918,047 |
31,404,074 |
RGD:6480464 |
CTD |
| G |
Klf2 |
Kruppel-like factor 2 (lung) |
|
increases expression |
EXP |
16 |
17,941,780 |
17,943,730 |
RGD:6480464 |
CTD |
| G |
Klhl2 |
kelch-like family member 2 |
|
increases expression |
EXP |
16 |
26,634,400 |
26,690,756 |
RGD:6480464 |
CTD |
| G |
Klhl7 |
kelch-like family member 7 |
|
increases expression |
EXP |
4 |
6,373,343 |
6,422,371 |
RGD:6480464 |
CTD |
| G |
Krit1 |
KRIT1, ankyrin repeat containing |
|
increases expression |
EXP |
4 |
27,014,488 |
27,048,636 |
RGD:6480464 |
CTD |
| G |
Krt2 |
keratin 2 |
|
increases expression |
ISO |
7 |
140,500,902 |
140,507,590 |
RGD:6480464 |
CTD |
| G |
Lama2 |
laminin, alpha 2 |
|
increases expression |
EXP |
1 |
18,203,466 |
18,885,462 |
RGD:6480464 |
CTD |
| G |
Lap3 |
leucine aminopeptidase 3 |
|
affects expression |
EXP |
14 |
70,680,077 |
70,699,061 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
increases expression |
ISO |
19 |
35,781,507 |
35,784,966 |
RGD:6480464 |
CTD |
| G |
Ldb2 |
LIM domain binding 2 |
|
increases expression |
EXP |
14 |
71,374,621 |
71,695,965 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
increases expression |
ISO |
6 |
40,253,664 |
40,297,195 |
RGD:6480464 |
CTD |
| G |
Lrba |
LPS-responsive vesicle trafficking, beach and anchor containing |
|
increases expression |
EXP |
2 |
178,257,272 |
178,787,626 |
RGD:6480464 |
CTD |
| G |
Lsm1 |
LSM1 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
|
decreases expression |
EXP |
16 |
70,652,831 |
70,663,995 |
RGD:6480464 |
CTD |
| G |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
|
increases expression |
EXP |
1 |
82,385,953 |
82,418,177 |
RGD:6480464 |
CTD |
| G |
Lypla1 |
lysophospholipase I |
|
increases expression |
EXP |
5 |
14,882,196 |
14,911,284 |
RGD:6480464 |
CTD |
| G |
Map1b |
microtubule-associated protein 1B |
|
increases expression |
ISO |
2 |
30,415,235 |
30,508,354 |
RGD:6480464 |
CTD |
| G |
Map3k4 |
mitogen activated protein kinase kinase kinase 4 |
|
increases expression |
EXP |
1 |
42,891,172 |
42,978,862 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapre3 |
microtubule-associated protein, RP/EB family, member 3 |
|
increases expression |
EXP |
6 |
25,496,282 |
25,506,449 |
RGD:6480464 |
CTD |
| G |
Mbl1 |
mannose-binding lectin (protein A) 1 |
|
decreases expression |
EXP |
16 |
17,591,820 |
17,597,859 |
RGD:6480464 |
CTD |
| G |
Mdk |
midkine |
|
increases expression |
ISO |
3 |
76,309,988 |
76,311,345 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
increases expression |
EXP |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Mex3d |
mex-3 homolog D (C. elegans) |
|
increases expression |
EXP |
7 |
10,832,697 |
10,844,164 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
increases expression |
EXP |
6 |
91,137,262 |
91,139,751 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases methylation |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
increases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
decreases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
increases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
decreases expression |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mrps18c |
mitochondrial ribosomal protein S18C |
|
increases expression |
EXP |
14 |
10,096,209 |
10,102,427 |
RGD:6480464 |
CTD |
| G |
Mtf2 |
metal response element binding transcription factor 2 |
|
increases expression |
EXP |
14 |
2,189,596 |
2,232,660 |
RGD:6480464 |
CTD |
| G |
Mthfd1l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
|
increases expression |
EXP |
1 |
34,759,445 |
34,800,865 |
RGD:6480464 |
CTD |
| G |
Mtx2 |
metaxin 2 |
|
increases expression |
EXP |
3 |
57,460,900 |
57,523,379 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
|
affects expression |
EXP |
X |
91,127,838 |
91,130,238 |
RGD:6480464 |
CTD |
| G |
Ncan |
neurocan |
|
increases expression |
ISO |
16 |
19,785,175 |
19,811,651 |
RGD:6480464 |
CTD |
| G |
Ncl |
nucleolin |
|
decreases expression |
EXP |
9 |
85,112,752 |
85,121,276 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Ndnl2 |
necdin-like 2 |
|
increases expression |
EXP |
1 |
119,276,434 |
119,278,432 |
RGD:6480464 |
CTD |
| G |
Nelfa |
negative elongation factor complex member A |
|
decreases expression |
EXP |
14 |
82,502,840 |
82,526,916 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases degradation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Ngly1 |
N-glycanase 1 |
|
increases expression |
EXP |
15 |
10,704,196 |
10,750,564 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Npas2 |
neuronal PAS domain protein 2 |
|
increases expression |
EXP |
9 |
38,255,362 |
38,434,352 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases expression |
EXP |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases localization |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases activity |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases expression |
EXP |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
increases expression |
EXP |
2 |
5,765,399 |
5,794,104 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
increases expression |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nt5dc1 |
5'-nucleotidase domain containing 1 |
|
increases expression |
EXP |
20 |
38,646,201 |
38,750,613 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
decreases expression |
ISO |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Nup153 |
nucleoporin 153 |
|
increases expression |
EXP |
17 |
24,031,666 |
24,084,210 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
|
decreases expression |
ISO |
10 |
61,955,348 |
62,037,871 |
RGD:6480464 |
CTD |
| G |
Pafah1b2 |
platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 |
|
decreases expression |
ISO |
8 |
48,938,556 |
48,957,109 |
RGD:6480464 |
CTD |
| G |
Pard6g |
par-6 partitioning defective 6 homolog gamma (C. elegans) |
|
increases expression |
EXP |
18 |
76,942,285 |
77,007,923 |
RGD:6480464 |
CTD |
| G |
Parg |
poly (ADP-ribose) glycohydrolase |
|
increases expression |
EXP |
16 |
7,689,492 |
7,798,104 |
RGD:6480464 |
CTD |
| G |
Pax3 |
paired box 3 |
|
decreases expression |
ISO |
9 |
77,477,813 |
77,576,632 |
RGD:6480464 |
CTD |
| G |
Pbx1 |
pre-B-cell leukemia homeobox 1 |
|
increases expression |
EXP |
13 |
83,839,256 |
84,115,516 |
RGD:6480464 |
CTD |
| G |
Pcyox1 |
prenylcysteine oxidase 1 |
|
increases expression |
EXP |
4 |
120,569,436 |
120,580,273 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
increases expression |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases expression |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases expression |
EXP |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases expression |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases expression |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases expression |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases expression |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pgrmc1 |
progesterone receptor membrane component 1 |
|
increases expression |
EXP |
X |
8,265,543 |
8,273,667 |
RGD:6480464 |
CTD |
| G |
Phf14 |
PHD finger protein 14 |
|
increases expression |
EXP |
4 |
37,147,379 |
37,253,334 |
RGD:6480464 |
CTD |
| G |
Pip4k2a |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
|
increases expression |
ISO |
17 |
92,950,531 |
93,111,944 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
decreases expression |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plcl1 |
phospholipase C-like 1 |
|
increases expression |
EXP |
9 |
54,207,542 |
54,546,228 |
RGD:6480464 |
CTD |
| G |
Plec |
plectin |
|
increases expression |
EXP |
7 |
114,202,742 |
114,262,385 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
increases expression |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Plxnb2 |
plexin B2 |
|
decreases expression |
ISO |
7 |
127,457,133 |
127,483,162 |
RGD:6480464 |
CTD |
| G |
Pnn |
pinin, desmosome associated protein |
|
increases expression |
EXP |
6 |
79,759,026 |
79,767,339 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
decreases expression |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases activity |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Pou3f1 |
POU class 3 homeobox 1 |
|
increases expression |
ISO |
5 |
143,981,547 |
143,984,527 |
RGD:6480464 |
CTD |
| G |
Ppil4 |
peptidylprolyl isomerase (cyclophilin)-like 4 |
|
increases expression |
EXP |
1 |
2,466,684 |
2,499,257 |
RGD:6480464 |
CTD |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
multiple interactions |
ISO |
11 |
86,951,420 |
87,169,229 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
decreases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prss12 |
protease, serine, 12 neurotrypsin (motopsin) |
|
increases expression |
ISO |
2 |
220,194,590 |
220,254,502 |
RGD:6480464 |
CTD |
| G |
Psip1 |
PC4 and SFRS1 interacting protein 1 |
|
increases expression |
EXP |
5 |
102,304,948 |
102,336,608 |
RGD:6480464 |
CTD |
| G |
Psmc6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
increases expression |
EXP |
15 |
21,217,367 |
21,239,320 |
RGD:6480464 |
CTD |
| G |
Psmd12 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 |
|
increases expression |
EXP |
10 |
96,881,373 |
96,907,258 |
RGD:6480464 |
CTD |
| G |
Ptbp2 |
polypyrimidine tract binding protein 2 |
|
increases expression |
EXP |
2 |
216,188,745 |
216,249,176 |
RGD:6480464 |
CTD |
| G |
Ptch1 |
patched 1 |
|
increases expression |
ISO |
17 |
7,088,234 |
7,142,459 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Rad50 |
RAD50 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
10 |
39,112,733 |
39,164,694 |
RGD:6480464 |
CTD |
| G |
Rai1 |
retinoic acid induced 1 |
|
increases expression |
EXP |
10 |
46,447,367 |
46,462,266 |
RGD:6480464 |
CTD |
| G |
Ranbp6 |
RAN binding protein 6 |
|
increases expression |
EXP |
1 |
233,518,476 |
233,522,997 |
RGD:6480464 |
CTD |
| G |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
|
increases expression |
EXP |
3 |
54,396,312 |
54,717,148 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
increases expression |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
decreases expression |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarg |
retinoic acid receptor, gamma |
|
increases expression |
ISO |
7 |
140,991,447 |
141,014,108 |
RGD:6480464 |
CTD |
| G |
Rbm12 |
RNA binding motif protein 12 |
|
increases expression |
EXP |
3 |
146,504,101 |
146,521,424 |
RGD:6480464 |
CTD |
| G |
Rbm3 |
RNA binding motif (RNP1, RRM) protein 3 |
|
increases expression |
EXP |
X |
26,379,303 |
26,382,739 |
RGD:6480464 |
CTD |
| G |
Rbm34 |
RNA binding motif protein 34 |
|
increases expression |
EXP |
19 |
56,864,501 |
56,885,217 |
RGD:6480464 |
CTD |
| G |
Rbp2 |
retinol binding protein 2, cellular |
|
increases expression |
ISO |
8 |
103,665,461 |
103,685,771 |
RGD:6480464 |
CTD |
| G |
Rdh14 |
retinol dehydrogenase 14 (all-trans/9-cis/11-cis) |
|
increases expression |
EXP |
6 |
33,867,711 |
33,872,853 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Riok2 |
RIO kinase 2 |
|
increases expression |
EXP |
1 |
55,897,247 |
55,913,533 |
RGD:6480464 |
CTD |
| G |
Rnaseh1 |
ribonuclease H1 |
|
decreases expression |
EXP |
6 |
46,528,591 |
46,537,960 |
RGD:6480464 |
CTD |
| G |
Rnd1 |
Rho family GTPase 1 |
|
increases expression |
EXP |
7 |
137,418,519 |
137,425,590 |
RGD:6480464 |
CTD |
| G |
Rnf115 |
ring finger protein 115 |
|
increases expression |
EXP |
2 |
191,528,021 |
191,596,690 |
RGD:6480464 |
CTD |
| G |
Rpe |
ribulose-5-phosphate-3-epimerase |
|
increases expression |
EXP |
9 |
65,470,071 |
65,490,200 |
RGD:6480464 |
CTD |
| G |
Rpl28 |
ribosomal protein L28 |
|
increases expression |
ISO |
1 |
67,768,597 |
67,771,158 |
RGD:6480464 |
CTD |
| G |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
|
increases expression |
EXP |
X |
56,722,878 |
56,825,444 |
RGD:6480464 |
CTD |
| G |
Rsrc1 |
arginine/serine-rich coiled-coil 1 |
|
decreases expression |
EXP |
2 |
156,889,768 |
157,213,294 |
RGD:6480464 |
CTD |
| G |
RT1-CE7 |
RT1 class I, locus CE7 |
|
affects response to substance |
ISO |
20 |
3,410,094 |
3,413,041 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
increases expression |
EXP |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
S100a10 |
S100 calcium binding protein A10 |
|
increases expression |
ISO |
2 |
186,645,674 |
186,654,321 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
increases expression |
ISO |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
Sart3 |
squamous cell carcinoma antigen recognized by T-cells 3 |
|
increases expression |
EXP |
12 |
43,893,486 |
43,921,131 |
RGD:6480464 |
CTD |
| G |
Sc5d |
sterol-C5-desaturase |
|
increases expression |
ISO |
8 |
45,229,976 |
45,238,924 |
RGD:6480464 |
CTD |
| G |
Scaf1 |
SR-related CTD-associated factor 1 |
|
increases expression |
EXP |
1 |
95,475,611 |
95,485,819 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
decreases expression |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scn1a |
sodium channel, voltage-gated, type I, alpha |
|
affects response to substance |
ISO |
3 |
48,238,528 |
48,364,143 |
RGD:6480464 |
CTD |
| G |
Scn1a |
sodium channel, voltage-gated, type I, alpha |
|
affects response to substance |
ISO |
3 |
48,238,528 |
48,364,143 |
RGD:6480464 |
CTD |
| G |
Scn1b |
sodium channel, voltage-gated, type I, beta |
|
affects binding |
ISO |
1 |
86,162,254 |
86,172,128 |
RGD:6480464 |
CTD |
| G |
Scn1b |
sodium channel, voltage-gated, type I, beta |
|
multiple interactions |
ISO |
1 |
86,162,254 |
86,172,128 |
RGD:6480464 |
CTD |
| G |
Scn1b |
sodium channel, voltage-gated, type I, beta |
|
decreases response to substance |
ISO |
1 |
86,162,254 |
86,172,128 |
RGD:6480464 |
CTD |
| G |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
|
multiple interactions |
ISO |
3 |
47,501,895 |
47,512,863 |
RGD:6480464 |
CTD |
| G |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
|
affects binding |
ISO |
3 |
47,501,895 |
47,512,863 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
decreases expression |
ISO |
3 |
155,446,138 |
155,464,825 |
RGD:6480464 |
CTD |
| G |
Sele |
selectin E |
|
multiple interactions |
ISO |
13 |
79,813,455 |
79,822,845 |
RGD:6480464 |
CTD |
| G |
Senp7 |
SUMO1/sentrin specific peptidase 7 |
|
increases expression |
EXP |
11 |
45,390,458 |
45,539,624 |
RGD:6480464 |
CTD |
| G |
Serpinc1 |
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
|
multiple interactions |
ISO |
13 |
76,548,456 |
76,562,724 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Sh3yl1 |
SH3 domain containing, Ysc84-like 1 (S. cerevisiae) |
|
increases expression |
EXP |
6 |
48,799,328 |
48,842,807 |
RGD:6480464 |
CTD |
| G |
Siah1a |
seven in absentia 1A |
|
increases expression |
EXP |
19 |
21,717,141 |
21,740,751 |
RGD:6480464 |
CTD |
| G |
Sipa1l1 |
signal-induced proliferation-associated 1 like 1 |
|
increases expression |
EXP |
6 |
106,171,896 |
106,283,008 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
decreases expression |
EXP |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Slc4a3 |
solute carrier family 4 (anion exchanger), member 3 |
|
increases expression |
EXP |
9 |
74,823,769 |
74,835,860 |
RGD:6480464 |
CTD |
| G |
Smarca1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
|
increases expression |
EXP |
X |
134,177,345 |
134,249,029 |
RGD:6480464 |
CTD |
| G |
Smarca5 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
|
increases expression |
EXP |
19 |
29,122,301 |
29,155,293 |
RGD:6480464 |
CTD |
| G |
Smc2 |
structural maintenance of chromosomes 2 |
|
increases expression |
EXP |
5 |
69,561,142 |
69,607,373 |
RGD:6480464 |
CTD |
| G |
Smc3 |
structural maintenance of chromosomes 3 |
|
increases expression |
ISO |
1 |
259,822,480 |
259,865,602 |
RGD:6480464 |
CTD |
| G |
Smc5 |
structural maintenance of chromosomes 5 |
|
increases expression |
EXP |
1 |
226,494,137 |
226,566,143 |
RGD:6480464 |
CTD |
| G |
Snx2 |
sorting nexin 2 |
|
increases expression |
EXP |
18 |
48,642,904 |
48,684,466 |
RGD:6480464 |
CTD |
| G |
Sp3 |
Sp3 transcription factor |
|
increases expression |
ISO |
3 |
55,440,985 |
55,485,768 |
RGD:6480464 |
CTD |
| G |
St13 |
suppression of tumorigenicity 13 |
|
increases expression |
EXP |
7 |
119,694,123 |
119,728,936 |
RGD:6480464 |
CTD |
| G |
Stat4 |
signal transducer and activator of transcription 4 |
|
decreases expression |
ISO |
9 |
46,510,251 |
46,650,076 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
decreases expression |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
decreases expression |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1d1 |
sulfotransferase family 1D, member 1 |
|
increases expression |
EXP |
14 |
21,983,705 |
22,002,744 |
RGD:6480464 |
CTD |
| G |
Sult2a1 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
|
decreases expression |
EXP |
1 |
75,632,632 |
75,708,022 |
RGD:6480464 |
CTD |
| G |
Sypl1 |
synaptophysin-like 1 |
|
increases expression |
EXP |
6 |
51,284,538 |
51,303,975 |
RGD:6480464 |
CTD |
| G |
Taf9b |
TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
increases expression |
EXP |
X |
94,342,071 |
94,351,927 |
RGD:6480464 |
CTD |
| G |
Tceal1 |
transcription elongation factor A (SII)-like 1 |
|
increases expression |
EXP |
X |
124,358,772 |
124,360,683 |
RGD:6480464 |
CTD |
| G |
Terf1 |
telomeric repeat binding factor (NIMA-interacting) 1 |
|
increases expression |
EXP |
5 |
2,556,918 |
2,586,086 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
decreases expression |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
increases expression |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Thoc6 |
THO complex 6 homolog (Drosophila) |
|
decreases expression |
EXP |
10 |
12,933,304 |
12,938,664 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tkt |
transketolase |
|
increases expression |
EXP |
16 |
5,908,759 |
5,933,695 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53bp2 |
tumor protein p53 binding protein, 2 |
|
increases expression |
EXP |
13 |
98,432,144 |
98,468,555 |
RGD:6480464 |
CTD |
| G |
Tradd |
TNFRSF1A-associated via death domain |
|
multiple interactions |
ISO |
19 |
35,073,150 |
35,075,251 |
RGD:6480464 |
CTD |
| G |
Trmt10b |
tRNA methyltransferase 10 homolog B (S. cerevisiae) |
|
increases expression |
EXP |
5 |
61,853,683 |
61,877,298 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
EXP |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Ube2d2 |
ubiquitin-conjugating enzyme E2D 2 |
|
increases expression |
EXP |
18 |
28,426,503 |
28,434,785 |
RGD:6480464 |
CTD |
| G |
Ubl5 |
ubiquitin-like 5 |
|
decreases expression |
EXP |
8 |
19,663,626 |
19,665,339 |
RGD:6480464 |
CTD |
| G |
Ubr1 |
ubiquitin protein ligase E3 component n-recognin 1 |
|
increases expression |
EXP |
3 |
107,632,668 |
107,746,611 |
RGD:6480464 |
CTD |
| G |
Ugdh |
UDP-glucose 6-dehydrogenase |
|
decreases expression |
EXP |
14 |
45,542,781 |
45,570,961 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
affects expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
EXP |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression |
EXP |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt2b17 |
UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
increases expression |
EXP |
14 |
22,639,182 |
22,650,931 |
RGD:6480464 |
CTD |
| G |
Ung |
uracil-DNA glycosylase |
|
multiple interactions |
ISO |
12 |
43,520,629 |
43,528,873 |
RGD:6480464 |
CTD |
| G |
Vars2 |
valyl-tRNA synthetase 2, mitochondrial |
|
increases expression |
EXP |
20 |
3,228,063 |
3,238,909 |
RGD:6480464 |
CTD |
| G |
Vcan |
versican |
|
increases expression |
ISO |
2 |
19,712,629 |
19,801,443 |
RGD:6480464 |
CTD |
| G |
Vegfb |
vascular endothelial growth factor B |
|
decreases expression |
ISO |
1 |
209,657,632 |
209,661,271 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
increases expression |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Wnt1 |
wingless-type MMTV integration site family, member 1 |
|
decreases expression |
ISO |
7 |
137,557,836 |
137,561,883 |
RGD:6480464 |
CTD |
| G |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
multiple interactions |
ISO |
2 |
19,904,490 |
20,158,358 |
RGD:6480464 |
CTD |
| G |
Yme1l1 |
YME1-like 1 (S. cerevisiae) |
|
increases expression |
EXP |
17 |
96,758,634 |
96,796,686 |
RGD:6480464 |
CTD |
| G |
Zap70 |
zeta-chain (TCR) associated protein kinase 70 |
|
decreases expression |
ISO |
9 |
35,693,089 |
35,715,071 |
RGD:6480464 |
CTD |
| G |
Zcchc11 |
zinc finger, CCHC domain containing 11 |
|
increases expression |
EXP |
5 |
129,565,023 |
129,860,103 |
RGD:6480464 |
CTD |
| G |
Zfp131 |
zinc finger protein 131 |
|
increases expression |
EXP |
2 |
51,817,650 |
51,844,634 |
RGD:6480464 |
CTD |
| G |
Zfp503 |
zinc finger protein 503 |
|
increases expression |
EXP |
15 |
2,352,911 |
2,356,699 |
RGD:6480464 |
CTD |
| G |
Zfp638 |
zinc finger protein 638 |
|
increases expression |
EXP |
4 |
118,113,122 |
118,190,703 |
RGD:6480464 |
CTD |
| G |
Zscan21 |
zinc finger and SCAN domain containing 21 |
|
increases expression |
EXP |
12 |
17,562,312 |
17,578,086 |
RGD:6480464 |
CTD |
Term paths to the root
|